$11.550
0.000 (0.00%)At close
EURK Profitability and Margins
Evaluating the bottom line, Eureka Acquisition Corp maintains a gross margin of N/A. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at N/A, while the net margin is N/A. These profitability ratios, combined with a Return on Equity (ROE) of 1.14%, provide a clear picture of how effectively EURK converts its operational activities into shareholder value.
EURK Comparative Benchmarking
In the context of the broader market, EURK competes directly with industry leaders such as TGE and ASPC. With a market capitalization of $25.06M, it holds a leading position in the sector. When comparing efficiency, EURK's gross margin of N/A stands against TGE's N/A and ASPC's N/A. Such benchmarking helps identify whether Eureka Acquisition Corp is trading at a premium or discount relative to its financial performance.
Eureka Acquisition Corp Financial Performance
The company has shown fluctuating net income, with a recent loss of $118,289 in Q1 2026, and a declining trend in current assets, which fell to $97,898 in Q3 2026. The current ratio is low at 0.00, indicating potential liquidity issues.
Financials
Related articles
- How to Rebalance a Concentrated Stock Portfolio in 2026: Mag7 Drift, Tax-Aware Trims, and Practical Rebalance a concentrated stock portfolio in 2026: Mag7 drift risk, 5pp bands, tax-aware trims, RSP/IWM diversifiers, and single-name caps.
- Small Cap Stocks Investing Guide 2026: Russell 2000, Fed Hikes, and the Financing TradeSmall-cap stocks investing guide 2026: Russell 2000 vs S&P, IWM rate sensitivity, floating-rate debt, Fed hikes, valuation discounts, and a practical checklist.
- Santa Claus Rally and the Year-End Stock Market: Investor Guide for Late 2026Santa Claus rally explained: 7-day window stats since 1950, Nov–Dec seasonality, post-midterm 2026 setup, and a risk-managed year-end investing playbook.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.